금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stocks Rise Pre-Bell as Traders Await Fed Policy Decision, Inflation Report, Big Tech Earnings
The benchmark US stock measures pointed higher before the opening bell Monday as traders gear up for...
Stock market today: Dow, S&P 500, Nasdaq futures rise ahead of busy week of earnings, Fed rate decision
Investors braced for a full earnings docket and the Federal Reserve's next policy decision this week...
British Pound: Stronger PMIs lean hawkish for BoE – Danske Bank
Danske Research Team notes UK flash PMIs strengthened in October, with the composite rising to 53.1 ...
Persian Gulf Outlook, Tech Strength Hoist Wall Street Pre-Bell; Asia Up, Europe Flat
Wall Street futures pointed moderately higher pre-bell Wednesday on media reports of possible 60-day
Citadel surges 6% after swoop on Situational Awareness
The flagship fund of Ken Griffin’s Citadel gained 5.9 per cent in July after it bought billions of dollars of AI stocks in a fire sale from Leopold...
SolarEdge Technologies beats top-line and bottom-line estimates; gives Q3 outlook
Zacks Investment Ideas feature highlights: Microsoft, Bloom and EMCOR
Microsoft, Bloom and EMCOR have been highlighted in this Investment Ideas article.
Earnings Snapshot: Eli Lilly tops forecasts on 60% volume surge, pushing revenue to $23B amid strong Mounjaro, Zepbound sales
Circle stock jumps as Q2 earnings beat estimates, USDC prospect seemingly intact
Capri beats top-line and bottom-line estimates; gives Q2 and updates FY26 outlook
AI-driven tech melt-up fuels $3.5T Nasdaq 100 surge in four days
Materion Non-GAAP EPS of $1.90 beats by $0.38, revenue of $613.9M beats by $64.08M
AMD, Nvidia, Intel, Booking, and More Stocks That Explain Today’s Market
FEATURE Stock futures were rising on Wednesday, putting both the and the on track to notch record highs. SpaceX slumped 11% in premarket trading after the rockets, telecom, and AI company beat analy ...
Ridgepost Capital Non-GAAP EPS of $0.24 beats by $0.01, revenue of $80.9M beats by $0.1M
Ultragenyx anticipates 2 gene therapy PDUFAs in August/September 2026 while targeting profitability in 2027